BioSpace News Archive

Amryt Pharma plc (“Amryt” or the “Company”) Update on AP101 EASE Phase III trial

IDMC recommends study can enrol children and infants aged from 21 days to 4 years

February 28, 2019

·

3 min read

Medigene AG: Medigene presents poster on in vitro evaluation of TCR efficacy and toxicity at AACR

Medigene AG announced that researchers of the Company will present a poster at the 2019 American Association for Cancer Research Annual Meeting.

February 28, 2019

·

2 min read

Global Food Industries reaps two topmost awards for Innovation excellence at UAE Innovation Awards 2019

February 28, 2019

·

4 min read

Medtronic Announces Approval and Launch of Japan’s First DBM Bone Grafting Product for Spine and Orthopedic Procedures

Grafton(TM) DBM Product Will Provide More Options for Spine and Orthopedic Surgeons in Japan

February 28, 2019

·

2 min read

Biotech Beach

Retrophin Recognizes Rare Disease Day® 2019 and Honors People Living with Rare Disease and Their Caregivers

Retrophin, Inc. joins the National Organization for Rare Disorders, the European Organisation for Rare Diseases, and others worldwide to recognize Rare Disease Day® 2019.

February 28, 2019

·

4 min read

Business

Evotec Receives Milestone Payment For Start Of Second Phase Ii Trial In Its Multi-target Alliance With Bayer

Evotec AG announced that another promising small molecule from its multi-target alliance with Bayer has advanced into Phase II clinical development for the treatment of persistent chronic cough.

February 28, 2019

·

3 min read

BioCapital

Vantage Report 2018: Research Dragged, but Biotech IPOs and Startups Soared

Evaluate recently published the Vantage Pharma, Biotech and Medtech 2018 in review report. The annual report offers insights into the previous year’s activities in biopharma and the medical device industry.

February 28, 2019

·

5 min read

·

Mark Terry

Business

Maze Therapeutics Opens Its Doors to Study Modifier Gene-Related Diseases

The company will focus on what are dubbed modifier genes. Essentially, two people with the same disease-causing genetic mutations often show varying degrees of illness, or in some cases, none at all.

February 28, 2019

·

2 min read

·

Mark Terry

Pharm Country

American Regent Announces the Re-Introduction of Aminocaproic Acid Injection, USP; AP Rated and Therapeutically Equivalent to Amicar®*(1)

American Regent announced the re-introduction of Aminocaproic Acid Injection, USP, a therapeutically equivalent generic alternative to Amicar®.

February 28, 2019

·

7 min read

Pharm Country

Physicians’ Education Resource® to Present Evolutions in the Treatment and Management of Advanced Cervical Cancer: Leveraging the Immunosuppressive Microenvironment, Addressing Ongoing Clinical Needs

The educational activity will take place as a satellite symposium adjunct to the Society of Gynecologic Oncology’s (SGO) 50th Annual Meeting on Women’s Cancer

February 28, 2019

·

3 min read